Research Article

Safety Evaluation of the Coagulase-Negative Staphylococci Microbiota of Salami: Superantigenic Toxin Production and Antimicrobial Resistance

Table 4

Minimal inhibitory concentration (MIC) of compounds used in antimicrobial therapy against staphylococci infections.

Salami originGenBank accession number and similarity (%)MIC mg mL−1
MethicillinAmpicillinVancomycinLinezolid

Commercial S. carnosus KJ862002.10.060.03
S. xylosus CP008724.10.060.030.06
S. saprophyticus JX490122.10.060.030.5
S. saprophyticus AB697717.10.5
S. saprophyticus EU430992.10.250.125
S. succinus KC329824.10.060.250.03

ArtisanalS. hominis. JX519988.10.060.5
S. saprophyticus HF937252.10.03
S. xylosus KF198080.10.030.5
S. saprophyticus KJ699151.10.50.250.03
S. saprophyticus KJ004623.10.50.030.03
S. xylosus CP007208.10.060.25

Strains S. epidermidis KF600589.1 and Staphylococcus spp. KF135445.1 were not susceptible to the antimicrobial concentrations tested in the present study.